News
Dec 2 2021 | Stanford Daily
An experimental brain stimulation approach developed at Stanford may provide a “revolutionary” treatment for severe depression, according to new data from Wu Tsai Neuro faculty affiliate Nolan Williams and colleagues.
Dec 1 2021 | Stanford News
Stanford University engineers Mark Cutkosky, a Wu Tsai Neurosciences Institute faculty affiliate, and David Lentink – now at University of Groningen in the Netherlands – have developed a perching robot that can fly around, catch and carry objects and perch on various surfaces.
Nov 29 2021 | Scope Blog
At its core, the Wu Tsai Neurosciences institute strives to harness the full collective intellectual power of Stanford to solve some of the most challenging questions in science: the nature of the three pounds of tissue that produces our experiences, memories and dreams, and how to keep it healthy...
Nov 24 2021 | Stanford Magazine
Sensors, samples, sequencing, scans. Meet Wu Tsai Neuro affiliate Michael Snyder, who may be the world’s most quantified human, and learn why he thinks his approach can fix what ails our health care system.
Nov 16 2021 | Stanford Report
Wu Tsai Neurosciences Institute benefactor Clara Wu Tsai, a businesswoman, investor and philanthropist, will begin a five-year term on Dec. 1.
Nov 15 2021 | Stanford Engineering
A Stanford AI team creates benchmarks for 100 everyday household tasks for robot assistants, creating a path for more useful agents.
Nov 15 2021 | Stanford News
Dancing droplets of food coloring housed in hand-drawn lattices could reveal the inner-workings of advanced materials and complex natural systems.
Nov 12 2021 | Stanford News
Working at the intersection of hardware and software engineering, researchers are developing new techniques for improving 3D displays for virtual and augmented reality technologies.
Nov 1 2021 | Scope Blog
Among the research projects that Stanford Medicine scientists are running to help people regain lost functions of the brain or nervous system are some designed to help people with vision loss see again.
Oct 31 2021 | Stanford Daily
Amit Etkin, formerly of the department of Psychiatry and Behavioral Sciences, steps away from Stanford to lead Alto Neuroscience Phase II trials of AI-guided psychotropic therapies.
